JPRN-UMIN000017654已完成未知
The study for simeprevir, peg-interferon, and ribavirin treatment efficacy against the patients with chronic hepatitis C (Multicenter trial) - The study for simeprevir, peg-interferon, and ribavirin treatment efficacy
Shinanomachi Liver Conference0 个研究点目标入组 200 人开始时间: 2015年5月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who were thought to be unsuitable
研究者
相似试验
已完成
不适用
Simeprevir in combination with peginterferon and ribavirin theraphy for Japanese chronic HCV patients: Significance of hepatic transporterChronic hepatitis CJPRN-UMIN000014003Juntendo University Nerima Hospital Department of Gastroenterology40
已完成
4 期
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney DiseaseChronic Hepatitis CNCT00028093National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)50
进行中（未招募）
不适用
Treatment with Peg-interferon alfa-2a and ribavirin in patients with hepatitis HCV-related, with or without HIV co-infection, and end stage renal disease on dialysis - NDChonic hepatitis HCV-relatedMedDRA version: 9.1Level: SOCClassification code 10019805MedDRA version: 9.1Level: SOCClassification code 10038359EUCTR2010-023245-30-ITISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI
已完成
不适用
Effect of pegylated interferon and ribavirin therapy on the QOL in the treatment of chronic hepatitis CJPRN-UMIN000003988Tokai University School of Medicine, Department of Internal Medicine, Division of Gastroenterology60
已完成
4 期
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3Hepatitis CNCT00056862National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)58